Search Within

Subhash C. Gulati

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (3)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (12)
  3. Hematologic Malignancies, Division of (9)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  5. Breast Medicine Service (7)
  6. Genitourinary Oncology Service (6)

More Groups

People
  1. John Crown (10)
  2. Lilian Reich (9)
  3. Larry Norton (7)
  4. Jeffrey Schneider (6)
  5. Robert Motzer (6)
  6. David Fennelly (5)

More People

Years
  1. 1994 (2)
  2. 1993 (6)
  3. 1992 (4)
Publications
  1. Blood (2)
  2. Cancer (2)
  3. JNCI: Journal of the National Cancer Institute (2)
  4. Journal of Clinical Oncology (2)
  5. Bone Marrow Transplantation (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. American Society of Hematology (2)
  3. Elsevier Inc. (2)
  4. Oxford University Press (2)
  5. Wiley Blackwell (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • High-intensity chemotherapy with peripheral blood progenitor cell support
    Conference Paper

    Fennelly, D.; Vahdat, L.; Schneider, J.; Reich, L.; Hamilton, N.; Hakes, T.; Raptis, G.; Wasserheit, C.; Kritz, A.; Gulati, S.; more...
    Elsevier Inc. (1994)

    Fulltext@MSK | Save
  • Superiority of high dose cyclophosphamide + GCSF versus either lower dose cyclophosphamide + GCSF or GCSF alone in mobilization of peripheral blood progenitor cells
    Meeting Abstract

    Vahdat, L.; Raptis, G.; Fennelly, D.; Reich, L.; Hamilton, N.; Yao, T. J.; Norton, L.; Gulati, S.; Crown, J.
    Blood (1993)

    Fulltext@MSK | Save
  • Peripheral blood progenitor supported high-dose chemotherapy: Determination of a threshold number of CD34+ cells for reliable engraftment
    Meeting Abstract

    Raptis, G.; Vahdat, L.; Fennelly, D.; Reich, L.; Hamilton, N.; Yao, T. J.; Bengala, C.; Schneider, J.; Shapiro, F.; Gulati, S.; more...
    Blood (1993)

    Fulltext@MSK | Save
  • Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
    Journal Article

    Motzer, R. J.; Mazumdar, M.; Gulati, S. C.; Bajorin, D. F.; Lyn, P.; Vlamis, V.; Bosl, G. J.
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save
  • Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer
    Journal Article

    Crown, J.; Kritz, A.; Vahdat, L.; Reich, L.; Moore, M.; Hamilton, N.; Schneider, J.; Harrison, M.; Gilewski, T.; Hudis, C.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors
    Journal Article

    Motzer, R. J.; Gulati, S. C.; Tong, W. P.; Menendez-Botet, C.; Lyn, P.; Mazumdar, M.; Vlamis, V.; Lin, S.; Bosl, G. J.
    Cancer Research (1993)

    Fulltext@MSK | Save
  • Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high‐dose chemotherapy plus granulocyte‐macrophage colony‐stimulating factor: A randomized trial
    Journal Article

    Kritz, A.; Crown, J. P.; Motzer, R. J.; Reich, L. M.; Heller, G.; Moore, M. P.; Hamilton, N.; Yao, T. J.; Heelan, R. T.; Schneider, J. G.; more...
    Cancer (1993)

    Fulltext@MSK | Save
  • Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells
    Journal Article

    Crown, J.; Wassherheit, C.; Hakes, T.; Fennelly, D.; Reich, L.; Moore, M.; Schneider, J.; Curtin, J.; Rubin, S. C.; Reichman, B.; more...
    JNCI: Journal of the National Cancer Institute (1992)

    Fulltext@MSK | Save
  • Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation
    Journal Article

    Gulati, S.; Yahalom, J.; Acaba, L.; Reich, L.; Motzer, R.; Crown, J.; Toia, M.; Igarashi, T.; Lemoli, R.; Hanninen, E.; more...
    Journal of Clinical Oncology (1992)

    Fulltext@MSK | Save